1型糖尿病中糖尿病相关遗传风险评分与残余β细胞功能的关联:GUTDM1研究
横断面研究纳入479例1型糖尿病患者,计算多种糖尿病相关遗传风险评分(GRS),分析其与尿C肽/肌酐比值及连续血糖监测指标的关系。结果显示较高的GRS-1和GRS-2与尿C肽/肌酐比值不可测相关,校正后关联减弱;较高的GRS-C2与可测的尿C肽/肌酐比值相关;较高的GRS-T2D与较低的低血糖时间比例和较低的血糖变异系数相关。结论认为糖尿病相关GRS与1型糖尿病患者的残余β细胞功能相关,提示遗传因素对β细胞功能保存有一定贡献。
要点
- 较高的GRS-1和GRS-2与尿C肽/肌酐比值不可测显著相关,校正后关联减弱。
- 较高的GRS-C2与可测的尿C肽/肌酐比值(≥0.01 nmol/mmol)相关(OR 6.95;95%CI 1.19,40.75)。
- 较高的GRS-T2D与较低的低血糖时间比例(TBR<4% OR 1.41;95%CI 1.01,1.96)和较低的血糖变异系数(β -1.53;95%CI -2.76,-0.29)相关。
核心结论
- 糖尿病相关遗传风险评分与1型糖尿病患者的残余β细胞功能相关,提示遗传因素对β细胞功能保存有一定贡献。
研究设计与样本
- 横断面队列研究,纳入479例1型糖尿病患者(年龄41.7±14.9岁,糖尿病病程16.0年[IQR 6.0-29.0],HbA1c 55.6±12.2 mmol/mol),使用Immunochip芯片和TOPMed进行基因分型,计算多种遗传风险评分。
主要发现
- 较高的GRS-1与尿C肽/肌酐比值不可测显著相关(OR 0.78;95%CI 0.69,0.89),校正病程后关联减弱。
- 较高的GRS-2与尿C肽/肌酐比值不可测显著相关(OR 0.84;95%CI 0.75,0.93),校正性别和发病年龄后关联减弱。
- 校正性别和发病年龄后,较高的GRS-C2与可测的尿C肽/肌酐比值(≥0.01 nmol/mmol)相关(OR 6.95;95%CI 1.19,40.75)。
- 较高的GRS-T2D与较低的低血糖时间比例相关(TBR<4%的OR 1.41;95%CI 1.01,1.96)。
- 较高的GRS-T2D与较低的血糖变异系数相关(β -1.53;95%CI -2.76,-0.29)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Use of genetic risk scores (GRS) may help to distinguish between type 1 diabetes and type 2 diabetes, but less is known about whether GRS are associated with disease severity or progression after diagnosis. Therefore, we tested whether GRS are associated with residual beta cell function and glycaemic control in individuals with type 1 diabetes. METHODS: Immunochip arrays and TOPMed were used to genotype a cross-sectional cohort (n=479, age 41.7 ± 14.9 years, duration of diabetes 16.0 years [IQR 6.0-29.0], HbA1c 55.6 ± 12.2 mmol/mol). Several GRS, which were originally developed to assess genetic risk of type 1 diabetes (GRS-1, GRS-2) and type 2 diabetes (GRS-T2D), were calculated. GRS-C1 and GRS-C2 were based on SNPs that have previously been shown to be associated with residual beta cell function. Regression models were used to investigate the association between GRS and residual beta cell function, assessed using the urinary C-peptide/creatinine ratio, and the association between GRS and continuous glucose monitor metrics. RESULTS: Higher GRS-1 and higher GRS-2 both showed a significant association with undetectable UCPCR (OR 0.78; 95% CI 0.69, 0.89 and OR 0.84: 95% CI 0.75, 0.93, respectively), which were attenuated after correction for sex and age of onset (GRS-2) and disease duration (GRS-1). Higher GRS-C2 was associated with detectable urinary C-peptide/creatinine ratio (≥0.01 nmol/mmol) after correction for sex and age of onset (OR 6.95; 95% CI 1.19, 40.75). A higher GRS-T2D was associated with less time below range (TBR) (OR for TBR<4% 1.41; 95% CI 1.01 to 1.96) and lower glucose coefficient of variance (β -1.53; 95% CI -2.76, -0.29). CONCLUSIONS/INTERPRETATION: Diabetes-related GRS are associated with residual beta cell function in individuals with type 1 diabetes. These findings suggest some genetic contribution to preservation of beta cell function.
引用
- Fuhri Snethlage CM, Balvers M, Ferwerda B, et al. Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study. Diabetologia. 2024. PMID: 38922416. doi:10.1007/s00125-024-06204-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。